Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-05-01 4:11 pm Purchase | 13G | TRAVERE THERAPEUTICS INC TVTX | Rock Springs Capital Management LP | 4,411,983 5.79% | 4,411,983 (New Position) | View |
2024-02-14 2:35 pm Purchase | 13G | TRAVERE THERAPEUTICS INC TVTX | ARMISTICE CAPITAL LLC | 7,384,000 9.83% | 972,000 (+15.16%) | View |
2024-02-14 08:58 am Purchase | 13G | TRAVERE THERAPEUTICS INC TVTX | Deep Track Capital LP | 7,522,281 9.99% | 2,940,281 (+64.17%) | View |
2024-02-14 06:38 am Purchase | 13G | TRAVERE THERAPEUTICS INC TVTX | MACQUARIE GROUP LTD | 4,746,144 6.31% | 1,190,152 (+33.47%) | View |
2024-02-13 5:16 pm Purchase | 13G | TRAVERE THERAPEUTICS INC TVTX | VANGUARD GROUP INC | 5,515,143 7.34% | 1,999,697 (+56.88%) | View |
2024-02-12 2:58 pm Sale | 13G | TRAVERE THERAPEUTICS INC TVTX | JANUS HENDERSON GROUP PLC JHG | 32,180 0% | -5,059,105 (-99.37%) | View |
2024-02-09 10:33 am Purchase | 13G | TRAVERE THERAPEUTICS INC TVTX | MORGAN STANLEY MS | 4,152,446 5.5% | 4,152,446 (New Position) | View |
2024-02-07 07:37 am Sale | 13G | TRAVERE THERAPEUTICS INC TVTX | ADAGE CAPITAL PARTNERS GP L.L.C. | 500,000 0.67% | -3,918,962 (-88.69%) | View |
2024-01-25 09:24 am Purchase | 13G | TRAVERE THERAPEUTICS INC TVTX | STATE STREET CORP STT | 5,352,345 7.12% | 1,128,321 (+26.71%) | View |
2024-01-24 09:46 am Purchase | 13G | TRAVERE THERAPEUTICS INC TVTX | BlackRock Inc. BLK | 7,990,020 10.6% | 287,792 (+3.74%) | View |
2023-10-06 2:34 pm Purchase | 13G | TRAVERE THERAPEUTICS INC TVTX | BlackRock Inc. BLK | 7,702,228 10.3% | 2,507,443 (+48.27%) | View |
2023-05-15 5:02 pm Sale | 13G | TRAVERE THERAPEUTICS INC TVTX | RA CAPITAL MANAGEMENT L.P. | 0 0% | -3,984,681 (Position Closed) | View |
2023-03-13 4:30 pm Purchase | 13G | TRAVERE THERAPEUTICS INC TVTX | ADAGE CAPITAL PARTNERS GP L.L.C. | 4,418,962 5.94% | 1,818,962 (+69.96%) | View |
2023-02-14 4:45 pm Sale | 13G | TRAVERE THERAPEUTICS INC TVTX | RA CAPITAL MANAGEMENT L.P. | 3,984,681 6.2% | -1,629,747 (-29.03%) | View |
2023-02-14 3:22 pm Sale | 13G | TRAVERE THERAPEUTICS INC TVTX | MACQUARIE GROUP LTD | 3,555,992 5.54% | -211,900 (-5.62%) | View |
2023-02-14 1:39 pm Purchase | 13G | TRAVERE THERAPEUTICS INC TVTX | ARMISTICE CAPITAL LLC | 6,412,000 9.99% | 2,334,000 (+57.23%) | View |
2023-02-14 08:59 am Purchase | 13G | TRAVERE THERAPEUTICS INC TVTX | Deep Track Capital LP | 4,582,000 7.14% | 1,146,800 (+33.38%) | View |
2023-02-10 5:27 pm Sale | 13G | TRAVERE THERAPEUTICS INC TVTX | GOLDMAN SACHS GROUP INC GS | 3,142,175 4.9% | -1,457,104 (-31.68%) | View |
2023-02-10 11:50 am Purchase | 13G | TRAVERE THERAPEUTICS INC TVTX | JANUS HENDERSON GROUP PLC JHG | 5,091,285 7.9% | 1,075,127 (+26.77%) | View |
2023-02-09 11:35 am Sale | 13G | TRAVERE THERAPEUTICS INC TVTX | VANGUARD GROUP INC | 3,515,446 5.48% | -365,427 (-9.42%) | View |